Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms 4Melanoma 4Skin Neoplasms 3Neoplasm Metastasis 2Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Otorhinolaryngologic Neoplasms 1Lip Neoplasms 1Laryngeal Diseases 1Head and Neck Neoplasms 1Carcinoma 1

Interventions

Cetuximab 13Cisplatin 8Radiotherapy, Intensity-Modulated 6Sorafenib 3Radiotherapy 3Paclitaxel 3Erlotinib Hydrochloride 3Docetaxel 3Carboplatin 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3Taxes 2Sirolimus 2Radiation 2Fluorouracil 2Everolimus 2Drug Therapy 2temsirolimus 1sargramostim 1saracatinib 1mercaptoundecahydrododecaborate 1ixabepilone 1cediranib 1advexin 1Zinc Oxide 1Vorinostat 1VTX-2337 1Ultrasonography 1Tobacco Use Cessation Devices 1Soybean Proteins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Tongue Neoplasms × Allovectin-7 × Clear all
NCT00050388 2008-06-24

Phase II Trial of Allovectin-7® for Head and Neck Cancer

Vical

Phase 3 Completed
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Head and Neck Neoplasms, Laryngeal Diseases, Lip Neoplasms, Neoplasms, Otorhinolaryngologic Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡